Citation:Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J 2006

Citation

Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol 2006 Jan;175(1):136-9; discussion 139 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16406890.

Critical appraisals

• Assign a critical appraisal

Cited by

1. What is the incidence of osteoporosis and reduction in bone mineral density at 2, 5 and 10 years and what is the risk of osteoporotic bone fracture due to bilateral orchidectomy (or orchidectomy), LHRH agonist or long term androgen deficiency?